KPI is a clinical-stage biopharma company focused on the development of new medicines that have the potential to transform the standard of care and save or improve patients’ lives. Our pipeline includes TriRima, a reversible inhibitor of monoamine oxidase-A (RIMA) for the treatment of depression, and KP544, a novel mechanism for the treatment of neurodegenerative disorders such as Alzheimer's Disease and prevention of neuropathy caused by chemotherapeutic agents.
View Top Employees from Krenitsky PharmaceuticalsWebsite | http://www.kpipharma.com |
Employees | 3 (1 on RocketReach) |
Founded | 1995 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing |
Looking for a particular Krenitsky Pharmaceuticals employee's phone or email?
Barry Brand is the Board Member of Krenitsky Pharmaceuticals.
1 people are employed at Krenitsky Pharmaceuticals.